EXOKERYX
Live / Applied — Ex parte appeal pending (as of 19 Mar 2026)
What this means for you
Not registered yet, but its 16 Nov 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97680953
- Mark type
- Stylized text
- Filed
- 16 Nov 2022
- Attorney of record
- John W. Olivo Jr.
Goods and services
- Class 001 — Chemicals: Kits comprising reagents, enzymes, enzyme substrates, antibodies, buffers, nucleic acids, biological agents, assays, for scientific, non-medical, or medical research use; Kits comprising reagents, enzymes, enzyme substrates, antibodies, buffers, nucleic acids, biological agents, and assays, conjugation chemistries, and chemical groups for scientific or medical research use; kits, reagents, enzymes, enzyme substrates, antibodies, buffers, nucleic acids, biological agents, assays, conjugation chemistries, and chemical groups for veterenary use; kits, comprising reagents, enzymes, enzyme substrates, monoclonal antibodies, buffers, nucleic acids, biological agents, and assays, for use in the fields of nucleic acid sequencing, proteomics, methylomics, metabolomics, diagnostics, diagnostic research, clinical research, drug development, pharmaceutical research, life sciences, exosomics, lipidomics, genetics, genomics, biotechnology, forensics, laboratory research, scientific research, medical research, oncology, neurodegeneration, infectious disease for scientific research
- Class 005 — Pharmaceuticals: Kits, reagents, enzymes, enzyme substrates, antibodies, buffers, nucleic acids, biological agents, assays, conjugation chemistries, and chemical groups for in vitro diagnostic use; kits, reagents, enzymes, enzyme substrates, antibodies, buffers, nucleic acids, biological agents, assays, conjugation chemistries, and chemical groups for veterenary use; kits, reagents, enzymes, enzyme substrates, antibodies, buffers, nucleic acids, biological agents, assays, conjugation chemistries, and chemical groups for clinical use; kits, comprising reagents, enzymes, enzyme substrates, monoclonal antibodies, buffers, nucleic acids, biological agents, and assays, for use in the fields of nucleic acid sequencing, proteomics, methylomics, metabolomics, diagnostics, diagnostic research, clinical research, drug development, pharmaceutical research, life sciences, exosomics, lipidomics, genetics, genomics, biotechnology, forensics, laboratory research, scientific research, medical research, oncology, neurodegeneration, infectious disease for medical purposes
Owner
- Exokeryx, Inc., San Diego, CA, US
Prosecution history
- 17 Mar 2026 — DIVISIONAL PROCESSING COMPLETE
- 27 Feb 2026 — DIVISIONAL REQUEST RECEIVED
- 27 Feb 2026 — TEAS REQUEST TO DIVIDE RECEIVED
- 12 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 21 Aug 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 21 Aug 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 21 Aug 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 24 Jan 2025 — JURISDICTION RESTORED TO EXAMINING ATTORNEY
- 04 Dec 2024 — NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
- 04 Dec 2024 — ACTION DENYING REQ FOR RECON E-MAILED
- 04 Dec 2024 — ACTION CONTINUING FINAL - COMPLETED
- 21 Nov 2024 — EX PARTE APPEAL-INSTITUTED
- 21 Nov 2024 — JURISDICTION RESTORED TO EXAMINING ATTORNEY
- 05 Nov 2024 — EXPARTE APPEAL RECEIVED AT TTAB
- 30 Oct 2024 — NOTICE OF REVIVAL - E-MAILED